A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosis

Cell Division

Volumn 6, Issue , 2011, Pages

  Bahassi, El Mustapha ^a   Yin, Moying ^a   Robbins, Susan B ^a   Li, Ya Qin ^a   Conrady, Deborah G ^a   Yuan, Zhenyu ^a   Kovall, Rhett A ^a   Herr, Andrew B ^a   Stambrook, Peter J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 79751527717     PISSN: None     EISSN: 17471028     Source Type: Journal    
DOI: 10.1186/1747-1028-6-4     Document Type: Article

References (32)

1. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439. 10.1038/35044005, 11100718.
2. Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 1998, 12:2973-2983. 10.1101/gad.12.19.2973, 9765199.
3. Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF. Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep 2000, 1:71-79. 10.1093/embo-reports/kvd018, 1083693, 11256629.
4. Zhao H, Watkins JL, Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci USA 2002, 99:14795-14800. 10.1073/pnas.182557299, 137498, 12399544.
5. Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J, Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000, 288:1425-1429. 10.1126/science.288.5470.1425, 10827953.
6. Bernardi R, Liebermann DA, Hoffman B. Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene 2000, 19:2447-2454. 10.1038/sj.onc.1203564, 10828887.
7. Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 2006, 18:185-191. 10.1016/j.ceb.2006.02.003, 16488126.
8. Busino L, Chiesa M, Draetta GF, Donzelli M. Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene 2004, 23:2050-2056. 10.1038/sj.onc.1207394, 15021892.
9. Chen MS, Ryan CE, Piwnica-Worms H. Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol 2003, 23:7488-7497. 10.1128/MCB.23.21.7488-7497.2003, 207598, 14559997.
10. Busino L, Donzelli M, Chiesa M, Guardavaccaro D, Ganoth D, Dorrello NV, Hershko A, Pagano M, Draetta GF. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 2003, 426:87-91. 10.1038/nature02082, 14603323.
11. Donzelli M, Squatrito M, Ganoth D, Hershko A, Pagano M, Draetta GF. Dual mode of degradation of Cdc25 A phosphatase. EMBO J 2002, 21:4875-4884. 10.1093/emboj/cdf491, 126287, 12234927.
12. Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, Harper JW. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev 2003, 17:3062-3074. 10.1101/gad.1157503, 305258, 14681206.
13. Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF, Kiyokawa H. Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol 2005, 25:3338-3347. 10.1128/MCB.25.8.3338-3347.2005, 1069597, 15798217.
14. Bartek J, Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 2001, 490:117-122. 10.1016/S0014-5793(01)02114-7, 11223026.
15. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410:842-847. 10.1038/35071124, 11298456.
16. Kristjansdottir K, Rudolph J. Cdc25 phosphatases and cancer. Chem Biol 2004, 11:1043-1051. 10.1016/j.chembiol.2004.07.007, 15324805.
17. Blomberg I, Hoffmann I. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol 1999, 19:6183-6194. 84557, 10454565.
18. Kang T, Wei Y, Honaker Y, Yamaguchi H, Appella E, Hung MC, Piwnica-Worms H. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell 2008, 13:36-47. 10.1016/j.ccr.2007.12.002, 2276649, 18167338.
19. Melixetian M, Klein DK, Sorensen CS, Helin K. NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nat Cell Biol 2009, 11:1247-1253. 10.1038/ncb1969, 19734889.
20. Isoda M, Kanemori Y, Nakajo N, Uchida S, Yamashita K, Ueno H, Sagata N. The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest. Mol Biol Cell 2009, 20:2186-2195. 10.1091/mbc.E09-01-0008, 2669026, 19244340.
21. NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA, Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases. , http://egp.gs.washington.edu
22. Karagoz ID, Ozaslan M, Cengiz B, Kalender ME, Kilic IH, Oztuzcu S, Gogebakan B, Demiryurek AT. CDC 25A gene 263C/T, -350C/T, and -51C/G polymorphisms in breast carcinoma. Tumour Biol 2010, 31:597-604. 10.1007/s13277-010-0075-z, 20614206.
23. Clucas C, Cabello J, Bussing I, Schnabel R, Johnstone IL. Oncogenic potential of a C. elegans cdc25 gene is demonstrated by a gain-of-function allele. EMBO J 2002, 21:665-674. 10.1093/emboj/21.4.665, 125848, 11847114.
24. Zou X, Tsutsui T, Ray D, Blomquist JF, Ichijo H, Ucker DS, Kiyokawa H. The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol Cell Biol 2001, 21:4818-4828. 10.1128/MCB.21.14.4818-4828.2001, 87174, 11416155.
25. Ray D, Terao Y, Nimbalkar D, Hirai H, Osmundson EC, Zou X, Franks R, Christov K, Kiyokawa H. Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice. Cancer Res 2007, 67:6605-6611. 10.1158/0008-5472.CAN-06-4815, 17638870.
26. Galaktionov K, Chen X, Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996, 382:511-517. 10.1038/382511a0, 8700224.
27. Fuhrmann G, Leisser C, Rosenberger G, Grusch M, Huettenbrenner S, Halama T, Mosberger I, Sasgary S, Cerni C, Krupitza G. Cdc25A phosphatase suppresses apoptosis induced by serum deprivation. Oncogene 2001, 20:4542-4553. 10.1038/sj.onc.1204499, 11494150.
28. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJ, Perstin J, Preston TJ, Wiley MJ, Wong AW. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 2009, 108:4-18. 10.1093/toxsci/kfn263, 19126598.
29. Laue TM, Shah BD, Ridgeway TM, Pelletier SM. Computer-aided interpretation of analytical sedimentation data for proteins. Analytical Ultracentrifugation in Biochemistry and Polymer Science 1992, 90-125. Cambridge: Royal Society of Chemistry, Harding SE, Rowe AJ, Hornton JC.
30. Johnson WC. Analyzing protein circular dichroism spectra for accurate secondary structures. Proteins 1999, 35:307-312. 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3, 10328265.
31. Whitmore L, Wallace BA. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 2004, 32:W668-673. 10.1093/nar/gkh371, 441509, 15215473.
32. Baratte B, Meijer L, Galaktionov K, Beach D. Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase. Anticancer Res 1992, 12:873-880.